Get started
ShaileshBhargaw

For Observation Purpose

Long
THYROCARE TECHNOL (NSE:THYROCARE)  
ShaileshBhargaw  
NSE:THYROCARE   THYROCARE TECHNOL
Trend Analysis
2
0
trendanalysis
Because of cutting cost of Co-Vi-d test from ₹950 ( Earlier Price )to ₹700(After Cutting Cost ) all Diagnostic share came down,
And If this go to ₹1,000 Today on Dec17 then it will reach up to ₹1,200 in next 7 session, otherwise wait for upcoming Support
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.